By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


DiagnoCure Inc. 

2050 Boulevard, Rene-Levesque Ouest, 6th Floor

Sainte-Foy  Quebec  G1V 2K8  Canada
Phone: 418-527-6100 Fax: 418-527-0240





Gen-Probe Incorporated (Acquired by Hologic)  In November 2003, Gen-Probe signed a license and collaboration agreement with DiagnoCure under which the companies are developing, and Gen-Probe will market, an innovative urine test to detect a new, highly specific genetic marker for prostate cancer called PCA3.

Company News
DiagnoCure (CUR) Announces Results Of Its Annual And Special Meeting Of Shareholders 5/20/2016 6:57:23 AM
DiagnoCure (CUR) Announces Its Decision To Proceed With The Voluntary Liquidation And Dissolution Of The Corporation 4/18/2016 8:17:32 AM
DiagnoCure (CUR) Announces First Quarter 2016 Results 3/14/2016 7:28:36 AM
DiagnoCure (CUR) Announces Closing Of The PCA3 Asset Sale Transaction And Special Distribution To Its Shareholders, By Way Of Due Bills, Of Proceeds From The Sale Of Its PCA3 Assets 2/18/2016 6:41:08 AM
DiagnoCure (CUR) Announces Results Of The Special Meeting Of Its Shareholders 2/15/2016 7:30:04 AM
DiagnoCure (CUR) Reports Recommendations From Two Independent Proxy Advisory Firms Favorable To The PCA3 Asset Sale And To The Reduction Of The Stated Capital 2/2/2016 6:25:46 AM
DiagnoCure (CUR) Announces Fourth Quarter 2015 And Year-End Results As Well As Proxy Circular Filing And Business Initiatives Following The Execution Of An Asset Purchase Agreement To Sell All Its Assets Relating To PCA3 1/22/2016 6:31:22 AM
DiagnoCure (CUR) Announces The Execution of an Asset Purchase Agreement With Hologic (HOLX) 12/28/2015 6:52:49 AM
DiagnoCure (CUR) Announces Third Quarter 2015 Results 9/11/2015 7:20:22 AM
DiagnoCure (CUR) Announces Second Quarter 2015 Results And Restructures Its Board Of Directors 6/12/2015 7:21:48 AM